Main navigation
- Home
- Epidermal growth factor receptor story
- EGFR in lung cancer
- Importance of EGFR mutation testing
- Obtaining tumour material for EGFR mutation testing
- Performing EGFR mutation testing
- Using test results to make a treatment decision
- Becoming an EGFR mutation testing laboratory
- EGFR resource centre
- Frequently asked questions about EGFR
- EGFR mutation testing eLearning modules
You are here
- Home
Frequently asked questions about EGFR
- What is EGFR?
- How is EGFR linked to cancer?
- What is gefitinib?
- How do tyrosine kinase inhibitors treat cancer?
- What types of mutations are commonly found in EGFR?
- Which exons of the EGFR gene are most likely to contain mutations?
- What is personalised therapy?
- My patient has locally advanced or metastatic non-small cell lung cancer – how do I obtain a sample for EGFR mutation testing?
- How do I perform EGFR mutation testing?
- What is the most appropriate sample for testing?
- How much tissue is needed to test for EGFR mutations?
- How are EGFR mutations detected?
- What is the difference between mutation screening and targeted mutation detection?
- Which mutations does the TheraScreen kit detect?
- What is the most appropriate sequencing strategy?
- What will the sequencing results look like?
- Is sequencing the only way to detect DNA mutations?
- Should we set up a test centre on-site or use a commercial lab?